Free
Letters to the Editor  |   August 2014
Author Response: Grating Visual Acuity in Infantile Nystagmus in the Absence of Image Motion
Author Affiliations & Notes
  • Matt J. Dunn
    School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom; and the
  • Tom H. Margrain
    School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom; and the
  • J. Margaret Woodhouse
    School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom; and the
  • Fergal A. Ennis
    School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom; and the
  • Christopher M. Harris
    Centre for Robotics and Neural Systems, Plymouth University, Plymouth, United Kingdom.
  • Jonathan T. Erichsen
    School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom; and the
Investigative Ophthalmology & Visual Science August 2014, Vol.55, 4955-4957. doi:https://doi.org/10.1167/iovs.14-15070
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Matt J. Dunn, Tom H. Margrain, J. Margaret Woodhouse, Fergal A. Ennis, Christopher M. Harris, Jonathan T. Erichsen; Author Response: Grating Visual Acuity in Infantile Nystagmus in the Absence of Image Motion. Invest. Ophthalmol. Vis. Sci. 2014;55(8):4955-4957. https://doi.org/10.1167/iovs.14-15070.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
We would like to thank Dell'Osso 1 for his critique of our work, as well as for highlighting the issue of visual acuity (VA) testing in the presence of infantile nystagmus (IN). It has long been assumed that VA could be improved by reducing the intensity of the nystagmus (i.e., the average velocity of the eye movements), and as cited by Dell'Osso, there are many such claims in the literature (discussed below). Over the last few decades, this intuitively appealing view has become entrenched as the theoretical basis for numerous therapeutic interventions. Indeed, Dell'Osso's critique of our study begins and ends by appealing to this notion, but we would remind him that intuition is no substitute for scientific rigor. 
Study Design
In our study, 2 we have demonstrated that there exists a fundamental underlying limitation in the VA of adults with IN, even in the absence of retinal image motion. By presenting grating stimuli using very brief flashes of light that were less than 1 ms in duration, we were able to virtually eliminate any motion blur induced by the eye movements themselves, thus unmasking the underlying VA. Subjects with IN and controls were tested under both constant and brief (tachistoscopic) lighting conditions. The brightness of the flash was adjusted so that control subjects showed no change in VA between the two conditions. However, contrary to the assumption that the eye movements of IN degrade VA, there was also no significant improvement whatsoever in subjects with IN when the effect of their eye movements (i.e., motion blur) was eliminated. 
Clearly, Dell'Osso has missed the point of our experiment. He erroneously states that we used a flash with a duration of 75 ms, whereas the duration was, in fact, only 0.76 ms. Such a brief presentation ensured that there was virtually no retinal smear caused by the nystagmus. His error is further compounded when he suggests that longer (i.e., 100 ms) presentations during foveating periods of the waveform might have worked better; a duration that long would produce substantial retinal smear and completely defeat the purpose of our experiment. Dell'Osso also expresses concern that the waveform characteristics of our participants might have affected the outcome. However, the fundamental premise of the experiment was to circumvent the eye movements altogether by eliminating image motion. Thus, our paradigm nullified the possible effect of waveform variations in order to provide a measure of the subjects' underlying spatial acuity threshold. For this reason, even if we were inclined to compute eXpanded Nystagmus Acuity Function (NAFX; an objective algorithm to characterize nystagmus waveforms), 3 it would have no meaning in this context. Moreover, the number of presentations available to each participant was unrestricted in order to overcome the possibility (as yet untested, despite Dell'Osso's claims) that detailed visual information cannot be gathered during nonfoveating portions of the waveform. The gratings used in our study were sufficiently large, so that the fovea was always pointing at the stimulus whenever the flash might have occurred. Dell'Osso also argues that poorer VA for vertical rather than horizontal gratings supports the notion that VA is limited by the horizontal nystagmus, and clearly dismisses the possibility of meridional amblyopia, as originally suggested by Abadi and King-Smith. 4  
Within-Subject Measurements of VA
In our paper, 2 we pointed out that a correlation between VA and various aspects of the nystagmus waveform (e.g., foveation duration, intensity, etc.) appears to be based on intersubject comparisons. In rebuttal, Dell'Osso 1 cites an impressive list of 12 papers in support of intrasubject improvement in VA, 516 but in our view, his interpretation exaggerates any such support. Close inspection reveals that only one of these papers actually provides statistical evidence of such a change, 15 as measured using standard letter charts. Of the other studies, six contained three or fewer subjects. 6,8,9,11,13,16 In fact, four of these studies only used one subject: Dell'Osso himself. 6,9,11,16 Two of the papers cited were reviews, and thus contained no new data, 10,12 while the remaining three found statistically significant changes in nystagmus waveform characteristics, but failed to detect significant changes in VA. 5,7,14 In three of these studies, 6,9,11 VA was not even measured, but instead NAFX was used as an outcome measure, from which VA was predicted. NAFX is a computed number based on waveform shape and does not include any perceptual component. Thus, these studies only confirm a change in waveform, and any claim that this reflects improvement in VA is completely circular. 
Despite the lack of clear evidence in the above studies, we are aware of a handful studies that have found a statistically significant change in VA in response to waveform modifications. These include the work of Hertle et al., 17 who showed improvements in VA following head posture surgery, and McLean et al., 18 who treated patients with memantine and gabapentin. We did not, and would not, suggest that VA cannot be improved at all in every subject with IN. On the basis of our results 2, 19,20 (and those of others 21,22 ), our conclusion was, and remains, that treatments that seek to slow the eye movements of adults with IN are likely to be fundamentally limited with regards to the improvements that can be expected in VA. 
What Is VA?
Crucially, none of the studies that purport to have found a change in VA used strict psychophysical procedures to determine the outcome. It is worth noting that all studies of IN that have involved such techniques (i.e., forced choice staircase procedure or similar) have failed to detect significant changes to VA in response to modifications of the waveform, whether through stress 19,21 or altered gaze angle. 20,22 Nonetheless, some individuals with IN report improvements in their ‘vision' following treatment, as well as when viewing using their preferred gaze angle (null zone). 
How might this discrepancy between VA measurement and subjective perceptual experience arise? In order to understand this, it is first worth reiterating the definition of VA, that is, the spatial resolution of a visual system. It has long been suspected that, due to difficulties in the accurate timing and deployment of gaze in IN, letter charts are inadequate as a sole measure of visual function. Wang and Dell'Osso 10 have published at least one study that reaches this same conclusion. 
The Limitations of Letter Charts
Letter charts are generally assumed to provide a pure measure of the spatial resolving power of the visual system, yet there are inherent time constraints. Any good clinician will know to give their patient plenty of time before responding to a chart, and this is especially true in the case of nystagmus. Nonetheless, viewing duration is limited by the ‘need to move on' to the next test, and the near absence of double-blind clinical trials in the IN literature makes it difficult to ensure that bias does not creep into the testing process when obtaining results (e.g., inadvertently allowing more time). In contrast, these issues are greatly reduced if not eliminated when using forced choice psychophysical testing. Hence, we argue that this level of discipline is necessary in order to claim that a therapeutic intervention is capable of eliciting improvements in spatial or any other visual function. Letter chart testing may ultimately turn out to be part of a sensitive test of overall visual function in IN. However, it is likely that changes in VA, as measured with a letter chart, may not represent an actual change in spatial acuity but rather intrinsically include a temporal aspect of visual performance, such as target acquisition latency, that may well be influenced by changes in nystagmus intensity and/or foveation duration. As Dell'Osso himself has argued, this is why eye movement based assessments of visual function are more appropriate in patients with IN. 9  
The participants in our experiment, who were comfortably seated and viewed stimuli using their null zone, did not benefit from the removal of retinal image motion. However, it remains possible that, in other studies, an unusually large increase in nystagmus intensity (e.g., due to stress owing to the prospect of undergoing experimental eye surgery) might result in a motion-blur–induced worsening of spatial acuity. Nevertheless, such a change in VA has repeatedly escaped detection in controlled psychophysical experiments. Cham et al. 19 and Jones et al. 21 both induced an increase in nystagmus intensity by introducing stress, but found no significant change in VA. Similarly, Erichsen et al. 20 and Yang et al. 22 systematically assessed VA at different gaze angles, and they too were unable to elicit statistically significant changes in VA. 
The Relationship Between Waveform and VA Between Subjects
The well documented correlation between VA and waveform parameters, when considering a range of different subjects with IN, remains to be explained. Intuitively, increasing the time the fovea spends directed toward the object of regard (i.e., increasing ‘foveation' duration) might be expected to improve the visual experience. Indeed, this has been demonstrated in control subjects. 23 However, in light of our results and those of others, any improvement in the vision of a given individual with IN is unlikely to involve a substantive change in spatial acuity per se. We suggested in our paper that the observed intersubject correlation may result from the waveform parameters, as measured by a metric such as NAFX, being ‘matched' during development to the available VA in a given subject. This is certainly consistent with a recent longitudinal study of nystagmus in young children. 24 An important implication of this view is that, if there truly is such a thing as ‘isolated' IN (i.e., IN in which there is no comorbid afferent visual system pathology), then reducing nystagmus intensity during the critical period for visual development might result in long-term improvements in VA. 
Summary
Attempting to measure visual changes using inappropriate tools may be doing a disservice to our patients. The subjective improvements to visual function that patients sometimes report following treatment are not consistent with the disappointing improvements obtained in ‘VA,' which, if they occur at all, are typically less than two lines on a chart. Indeed, the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, a staple in vision research, is known to be relatively insensitive to such small changes, even in the absence of nystagmus. 25 Directing our efforts toward more appropriate perceptual measures than VA alone may finally provide evidence to back up anecdotal reports for the usefulness of therapies. 
Dell'Osso 1 has claimed that our conclusions might be used to “deny effective treatment to nystagmus patients.” However, as we have discussed above, although the eye movements may be affected, VA has not been demonstrated to improve after changes to the waveform, which is entirely consistent with our results. Whether this reflects the inadequacy of VA as an outcome measure or the failure of such treatments to actually improve vision remains to be determined. The fact that at least some patients report “improved vision” means that we must strive to determine what other aspects of their vision, such as “time to see,” might be affected by a given treatment. Although waveform-measuring functions such as NAFX attempt to quantify any changes in visual performance, they are unfortunately predicated on aspects of spatial visual function (VA), which have repeatedly been shown to be relatively unmodifiable, when measured appropriately. 
References
Dell'Osso LF. Grating visual acuity in infantile nystagmus in the absence of image motion. Invest Ophthalmol Vis Sci . 2014; 55: 4952–4954. [CrossRef] [PubMed]
Dunn MJ Margrain TH Woodhouse JM Ennis F Harris CM Erichsen JT. Grating visual acuity in infantile nystagmus in the absence of image motion. Invest Ophthalmol Vis Sci . 2014; 55: 2682–2686. [CrossRef] [PubMed]
Dell'Osso LF Jacobs JB. An expanded nystagmus acuity function: intra- and intersubject prediction of best-corrected visual acuity. Doc Ophthalmol . 2002; 104: 249–276. [CrossRef] [PubMed]
Abadi RV King-Smith PE. Congenital nystagmus modifies orientational detection. Vis Res . 1979; 19: 1409–1411. [CrossRef] [PubMed]
Hertle RW Dell'Osso LF FitzGibbon EJ Thompson D Yang D Mellow SD. Horizontal rectus tenotomy in patients with congenital nystagmus: results in 10 adults. Ophthalmology . 2003; 110: 2097–2105. [CrossRef] [PubMed]
Dell'Osso LF Hertle RW Leigh RJ Jacobs JB King S Yaniglos S. Effects of topical brinzolamide on infantile nystagmus syndrome waveforms: eyedrops for nystagmus. J Neuroophthalmol . 2011; 31: 228–233. [PubMed]
Wang Z Dell'Osso LF Jacobs JB Burnstine RA Tomsak RL. Effects of tenotomy on patients with infantile nystagmus syndrome: foveation improvement over a broadened visual field. J AAPOS . 2006; 10: 552–560. [CrossRef] [PubMed]
Wang ZI Dell'Osso LF Tomsak RL Jacobs JB. Combining recessions (nystagmus and strabismus) with tenotomy improved visual function and decreased oscillopsia and diplopia in acquired downbeat nystagmus and in horizontal infantile nystagmus syndrome. J AAPOS . 2007; 11: 135–141. [CrossRef] [PubMed]
Taibbi G Wang ZI Dell'Osso LF. Infantile nystagmus syndrome: broadening the high-foveation-quality field with contact lenses. Clin Ophthalmol . 2008; 2: 585–590. [PubMed]
Wang ZI Dell'Osso LF. Eye-movement-based assessment of visual function in patients with infantile nystagmus syndrome. Optom Vis Sci . 2009; 86: 988–995. [CrossRef] [PubMed]
Thurtell MJ Dell'Osso LF Leigh RJ Matta M Jacobs JB Tomsak RL. Effects of acetazolamide on infantile nystagmus syndrome waveforms: comparisons to contact lenses and convergence in a well-studied subject. Open Ophthalmol J . 2010; 4: 42–51. [CrossRef] [PubMed]
Wang ZI Dell'Osso LF. A review of the tenotomy nystagmus surgery: origin, mechanism, and general efficacy. Neuroophthalmology . 2007; 31: 157–165. [CrossRef]
Dell'Osso LF Flynn JT. Congenital nystagmus surgery. A quantitative evaluation of the effects. Arch Ophthalmol . 1979; 97: 462–469. [CrossRef] [PubMed]
Hertle RW Dell'Osso LF FitzGibbon EJ Yang D Mellow SD. Horizontal rectus muscle tenotomy in children with infantile nystagmus syndrome: a pilot study. J AAPOS . 2004; 8: 539–548. [CrossRef] [PubMed]
Hertle RW Anninger W Yang D Shatnawi R Hill VM. Effects of extraocular muscle surgery on 15 patients with oculo-cutaneous albinism (OCA) and infantile nystagmus syndrome (INS). Am J Ophthalmol . 2004; 138: 978–987. [CrossRef] [PubMed]
Dell'Osso L Gauthier G Liberman G Stark L. Eye movement recordings as a diagnostic tool in a case of congenital nystagmus. Am J Optom Arch Am Acad Optom . 1972; 49: 3–13. [CrossRef] [PubMed]
Hertle RW Yang D Adams K Caterino R. Surgery for the treatment of vertical head posturing associated with infantile nystagmus syndrome: results in 24 patients. Clin Exp Ophthalmol . 2011; 39: 37–46.
McLean RJ Proudlock F Thomas S Degg C Gottlob I. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin. Ann Neurol . 2007; 61: 130–138. [CrossRef] [PubMed]
Jones PH Harris CM Woodhouse JM Margrain TH Ennis F Erichsen JT. Stress and visual function in infantile nystagmus syndrome. Invest Ophthalmol Vis Sci . 2013; 54: 7943–7951. [CrossRef] [PubMed]
Erichsen JT Wiggins D Woodhouse JM Margrain TH Harris CM. Effect of eye orientation on visual acuity in infantile nystagmus (INS). Abstract presented at 17th European Conference on Eye Movements ; Lund, Sweden; August 11–16, 2013; 514.
Cham KM Anderson AJ Abel LA. Task-induced stress and motivation decrease foveation-period durations in infantile nystagmus syndrome. Invest Ophthalmol Vis Sci . 2008; 49: 2977–2984. [CrossRef] [PubMed]
Yang DS Hertle RW Hill VM Stevens DJ. Gaze-dependent and time-restricted visual acuity measures in patients with Infantile Nystagmus Syndrome (INS). Am J Ophthalmol . 2005; 139: 716–718. [CrossRef] [PubMed]
Chung ST LaFrance MW Bedell HE. Influence of motion smear on visual acuity in simulated infantile nystagmus. Optom Vis Sci . 2011; 88: 200–207. [CrossRef] [PubMed]
Felius J Muhanna ZA. Visual deprivation and foveation characteristics both underlie visual acuity deficits in idiopathic infantile nystagmus. Invest Ophthalmol Vis Sci . 2013; 54: 3520–3525. [CrossRef] [PubMed]
Rosser DA Cousens SN Murdoch IE Fitzke FW Laidlaw DAH. How sensitive to clinical change are ETDRS logMAR visual acuity measurements? Invest Ophthalmol Vis Sci . 2003; 44: 3278–3281. [CrossRef] [PubMed]
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×